Market Overview

Benzinga's Top Pre-Market Losers

Related RVBD
Benzinga's M&A Chatter for Thursday November 20, 2014
Benzinga's M&A Chatter for Wednesday November 12, 2014
Related OPTR
HSR Waiting Period Expires for Cubist, Optimer Deal
Cubist Pharma Reports Pricing of $700M in Convertible Senior Notes, Expecting Proceeds of $679M

Riverbed Technology (NASDAQ: RVBD) dipped 17.46% to $14.47 in the pre-market session after the company reported downbeat second-quarter revenue.

Optimer Pharmaceuticals (NASDAQ: OPTR) shares fell 6.47% to $12.43 in the pre-market trading after Cubist Pharmaceuticals (NASDAQ: CBST) announced its plans to acquire Trius Therapeutics (NASDAQ: TSRX) and Optimer for up to $1.62 billion.

BioCryst Pharmaceuticals (NASDAQ: BCRX) shares dropped 5.78% to $3.75 in pre-market trading after the company announced its plans to sell up to $20 million in common stock.

Genworth Financial (NYSE: GNW) dipped 3.82% to $12.85 in the pre-market session after the company reported weaker-than-expected second-quarter results.

Posted-In: Top Pre-Market LosersNews Movers & Shakers Pre-Market Outlook Markets

 

Related Articles (BCRX + CBST)

Around the Web, We're Loving...

Get Benzinga's Newsletters